Podcast: Generic Biologics

A Senate committee has approved legislation to create an FDA regulatory pathway for generic biologics. Mary Agnes Carey, associate editor of CQ HealthBeat, comments on this recent activity.

If you are not automatically redirected, follow this link:

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments